FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Aortic Valve, Prosthesis, Percutaneously Delivered

PMA: P130021 · Supplement: S106 · Decision Dec 1, 2021
Classifications
1
FEI Numbers
24
Registration Numbers
24

Basic Information

Device Name
Aortic Valve, Prosthesis, Percutaneously Delivered
Trade Name
Medtronic CoreValve™ EnVeo™ R Delivery Catheter System, Medtronic CoreValve™ EnVeo™ Pro Delivery Catheter System, Medtro
PMA Number
P130021
Supplement Number
S106
Device Class
FDA Class 3
Product Code
NPT
Generic Name
Aortic valve, prosthesis, percutaneously delivered
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
December 1, 2021
Date Received
November 22, 2021
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Automation of an in-process inspection of the delivery catheter system.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPT Aortic Valve, Prosthesis, Percutaneously Delivered